Retinopathy is one of the most severe diabetes‐related complications, and macular edema
is the major cause of central vision loss in patients with diabetes mellitus. Significant …

As a common ocular complication and microangiopathy of type 2 diabetic mellitus, diabetic
retinopathy (DR) can lead to vision loss or even blindness in diabetic patients. At present …

Abstract Background/Objectives To study the mechanism of restoration of retinal
photoreceptor ellipsoid zone (EZ), after intravitreal bevacizumab (IVB) therapy, in diabetic …

Purpose. Ellipsoid zone (EZ) integrity is identified as a potential biomarker for therapy
surveillance and outcome prediction of visual acuity (VA). However, only a few studies report …

Purpose: To develop and train a deep learning-based algorithm for detecting
disorganization of retinal inner layers (DRIL) on optical coherence tomography (OCT) to …

Topic The goal of this review was to summarize the current level of evidence on biomarkers
to quantify diabetic retinal neurodegeneration (DRN) and diabetic macular edema (DME) …

Diabetic macular oedema (DMO) is an important cause of moderate vision loss in people
with diabetes. Advances in imaging technology have shown that a significant proportion of …

(1) Background: The global burden of diabetes mellitus (DM) has been estimated to reach
600 million patients worldwide by 2040. Approximately 200 million people will develop …

Diabetic retinopathy (DR), the most common microvascular complication of diabetes
mellitus, represents the leading cause of acquired blindness in the working-age population …

Purpose To analyze the morphological characteristics and long-term visual outcomes in
eyes with diabetic retinopathy (DR) and diabetic macular edema (DME) treated with anti …